Keywords: fda, allows, reintroduction, tysabri, after, review, biogen

FDA allows reintroduction of Tysabri, after review of Biogen's TOUCH scheme

Article | 12 June 2006

Print This

US firm Biogen Idec and Ireland's Elan say that the Food and Drug Administration has approved a supplemental Biologics License ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in